Medical device companies get a three-month extension for licences
The Central Drugs Standard Control Organization (CDSCO) has granted an extension of three months to existing manufacturers and importers of high-risk medical devices if they have applied for licences before September 30, 2023. “It has been decided that, in case, if an existing importer/manufacturer who is already importing/manufacturing any Class C or Class D medical […]
Read More
History of healthcare price control and its latest turn in India
Pavan Choudary, Chairman of Medical Technology Association of India (MTaI), Managing Director of Vygon India and a public intellectual stresses that throughout history there have been many instances of governments wanting to control prices. In most of these instances, the often-well-intentioned price control has inadvertently hurt access or at least brought down the quality of the […]
Read More
Govt expands committee for drugs, medical devices pricing reforms
The government has expanded the composition of the committee formed to look into pricing reforms for drugs and medical devices by admitting various industry bodies, according to a circular issued by the Ministry of Chemicals and Fertilisers. The committee, which was constituted by the Department of Pharmaceuticals on March 12, will now have representation from […]
Read More
Secretary DoP expounds concept of ‘Proximate Advantage’ at MTaI fraternity meeting in India
Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with a large footprint in manufacturing and training in India, recently organised a high–level meeting with government stakeholders, and MediTech industry captains in New Delhi. The event was graced by Dr Arunish Chawla, Secretary, Department of Pharmaceuticals (DoP), and MAseem Sahu, Deputy […]
Read More
Separate norms likely for regulating prices of medical devices
Price controls on pharmaceutical formulations and medical devices should be based separate set of rules, as the two are different product categories, a senior government official said, even as a government committee is set to review the decade-old Drug (Prices Control) Order (DPCO), 2013. Speaking to FE, Arunish Chawla, secretary at Department of Pharmaceuticals (DoP), […]
Read More
RBI’s decision on interest rate pragmatic, ensures sustainable growth: Experts
New Delhi: The Reserve Bank’s decision to keep the benchmark interest rate stable is pragmatic and will ensure sustainable economic growth, say experts. The RBI Monetary Policy Committee on Thursday decided to keep policy rate unchanged for the sixth time in a row in view of global uncertainty and the need to bring down retail […]
Read More
Interim Budget 2024: Health experts welcome emphasis on ‘social inclusivity’
The targeted areas in the health sector reflected the emphasis on “social inclusivity” by Union Finance Minister Nirmala Sitharaman in her Interim Budget 2024-25 speech. From extending Ayushman Bharat scheme to all ASHA, Anganwadi workers and helpers to encouraging cervical cancer immunization for girls in the age group of 9-14 to expedition of Poshan 2.0, […]
Read More
Budget 2024: Top reactions from healthcare industry leaders–Who said what on Nirmala Sitharaman’s announcements
Budget 2024: Finance Minister Sitharaman tabled the interim budget 2024 ahead of the Lok Sabha elections. During her budget speech, Sitharaman announced that healthcare cover under the Ayushman Bharat insurance scheme will be extended to all ASHA and anganwadi workers and helpers. Sitharaman also announced that the government will encourage vaccination for girls in the 9-14 year age […]
Read More